Researchers at the University of California, Davis, have partnered with a federally compliant pharmaceutical company to analyze the chemical and biological profiles of cannabis for the benefit of law enforcement, health care providers and scientific professionals.
The agreement with Biopharmaceutical Research Company, which is registered with the U.S. Drug Enforcement Administration, is among the first of its kind.
UC Davis and BRC researchers will analyze legally acquired cannabis materials in BRC’s labs to understand the chemical composition of tetrahydrocannabinol or THC, cannabidiol or CBD, and other cannabinoids.
There will be no cannabis on the UC Davis campus or any UC Davis-owned or leased property as part of this research.
Click here to read the complete article
Amy Quinton ~ UCDavis.edu ~
